
The Hidden Cost Behind Your “$0 Copay” Drug Assistance Program
Copay assistance programs are supposed to reduce drug costs and cover patients’ deductibles — so why are so many people getting stuck with a bill?
Deep dives into the political corruption and corporate bureaucracy that keeps Americans sick while making executives rich.
Copay assistance programs are supposed to reduce drug costs and cover patients’ deductibles — so why are so many people getting stuck with a bill?
Whole Foods workers are made whole, corporate criminals face the music, private equity loses its painkillers, and an empire of pain gets a taste of its own medicine.
Regulators approved controversial therapies amid excess deaths, questionable efficacy, and conflicts of interest.
Alzheimer’s Disease shrinks your brain — why do the new drugs for the condition do the same thing?
Drugmakers say small brain bleeds and swelling caused by the new Alzheimer’s drugs are benign and self-resolving — but are they?
A groundbreaking study finds doctors affiliated with hospitals and private equity firms are charging billions more annually than independent general practitioners.
While proponents claim direct-to-consumer drug ads educate consumers, critics say that mass-market misinformation is costing patients and taxpayers alike.
The Biden administration just delivered a sweetheart deal to its friends at McKinsey, letting the consulting giant off the hook for helping to “turbocharge” disastrous OxyContin sales.
Censorship gets banned, youth score a climate win, nurses win a major union vote, workers’ rights are clear and unmistakable, and small businesses go boom.
“Uber for nurses” is extracting profits and hurting health care, all to solve a problem that doesn’t exist.